Results 1 to 10 of about 131,157 (260)

QUO VADIS PSYCHIATRIC TREATMENTS? Seventy Years of Modern Psychopharmacology and Thirty Years of “Psychiatry and Clinical Psychopharmacology”

Psychiatry and Clinical Psychopharmacology, 2021
To cite this article: Cetin M, Aricioglu F, Dursun S. QUO VADIS PSYCHIATRIC TREATMENTS? Seventy Years of Modern Psychopharmacology and Thirty Years of “Psychiatry and Clinical Psychopharmacology”.
Mesut Cetin, Feyza Aricioglu, Serdar Dursun   +2 more
doaj   +1 more source

Psychiatric nosological historiography - Part II: psychopharmacology and somatogenic perspectives

Debates em Psiquiatria, 2023
Introduction: The history of psychiatry encompasses the evolving concepts about the relationship between body and mind and also of the definiton of normality, which depend on the knowledge and customs of different times and places.
Marleide de Mota Gomes, Mauro Vitor Mendlowicz, Antonio Egidio Nardi   +2 more
doaj   +1 more source

Impact of the Aversive Effects of Drugs on Their Use and Abuse

Behavioural Neurology, 2022
Drug use and abuse are complex issues in that the basis of each may involve different determinants and consequences, and the transition from one to the other may be equally multifaceted.
Anthony L. Riley, Hayley N. Manke, Shihui Huang   +2 more
doaj   +1 more source

Nanotechnology applications in neuroscience: Advances, opportunities and challenges

Psychiatry and Clinical Psychopharmacology, 2021
New treatment and prophylaxis needs, which have emerged as the incidence of central nervous system disorders (CNSDs) has increased, have brought two concepts together: neuroscience and nanotechology. Because of the restricton of the blood-brain barrier (
Mesut Cetin, Salih Gumru, Feyza Aricioglu   +2 more
doaj   +1 more source

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

Pharmacy, 2021
Although clinical pharmacy is a discipline that emerged in the 1960s, the question of precisely how pharmacists can play a role in therapeutic optimization remains unanswered.
Hervé Javelot, Clara Gitahy Falcao Faria, Frederik Vandenberghe, Sophie Dizet, Bastien Langrée, Mathilde Le Maout, Céline Straczek, Adeline Egron, Alexis Erb, Guillaume Sujol, Antoine Yrondi, Sébastien Weibel, Philippe D. Vincent, Guillaume Meyer, Coraline Hingray   +14 more
doaj   +1 more source

Solitary Nitric Oxide Signaling Mediates Mild Stress-Induced Anxiety and Norepinephrine Release in the Bed Nucleus of the Stria Terminalis during Protracted Ethanol Withdrawal

Behavioural Neurology, 2021
Ethanol withdrawal (EtOHW) alters the pattern of neurohormonal and behavioral response toward internal and external stimuli, which mediates relapse to alcohol use even after a long period of abstinence.
Zhenglin Zhao, Sang Chan Kim, Yu Jiao, Yefu Wang, Bong Hyo Lee, Hee Young Kim, Chul Won Lee, Chae Ha Yang, Rongjie Zhao   +8 more
doaj   +1 more source

Social Isolation, Loneliness and Generalized Anxiety: Implications and Associations during the COVID-19 Quarantine

Brain Sciences, 2021
The COVID-19 pandemic has resulted in a predominantly global quarantine response that has been associated with social isolation, loneliness, and anxiety.
Linas Wilkialis, Nelson B. Rodrigues, Danielle S. Cha, Ashley Siegel, Amna Majeed, Leanna M. W. Lui, Jocelyn K. Tamura, Barjot Gill, Kayla Teopiz, Roger S. McIntyre   +9 more
doaj   +1 more source

A mindful approach to controlling intrusive thoughts

Scientific Reports, 2023
Intrusive thoughts of negative experiences can pose a threat to our well-being. To some extent, unwanted memories can be intentionally controlled via an executive control mechanism that downregulates the occurrence of intrusions. Mindfulness training can
S. M. Ashton, A. Sambeth, C. W. E. M. Quaedflieg   +2 more
doaj   +1 more source

Improvement of conventional perception in stable patients with schizophrenia by add-on treatment with ipidacrine

European Psychiatry, 2021
Introduction Impairment of conventional perception is one of the key dysfunction in patients with schizophrenia even in absence of psychotic symptoms.
M. Morozova, S. Potanin, G. Rupchev, D. Burminskiy, T. Lepilkina, A. Beniashvili   +5 more
doaj   +1 more source

Today’s psychopharmacological treatments: results, problems, new perspectives

Psychiatry and Clinical Psychopharmacology, 2021
Despite all efforts even in the half of the first quarter of the twenty-first century, psychiatric disorders are still lifelong conditions, which cannot be treated fully and mostly continue to be chronic.
Mesut Cetin, Feyza Aricioglu, Cengiz Han Acikel, Selim Kilic   +3 more
doaj   +1 more source